Nanomedicine in the fight against thrombotic diseases
Future Science Group (FSG) today announced the publication of a new article in Future Science OA, covering the use of nanocarriers and microbubbles in drug delivery for thrombotic disease.
Future Science Group (FSG) today announced the publication of a new article in Future Science OA, covering the use of nanocarriers and microbubbles in drug delivery for thrombotic disease.
Bio & Medicine
Jul 6, 2015
0
44
Organic chemists at The Ohio State University have figured out how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs—including one most commonly ...
Materials Science
Oct 17, 2019
1
800
About one in four older adults suffers from chronic pain. Many of those people take medication, usually as pills. But this is not an ideal way of treating pain: Patients must take medicine frequently, and can suffer side ...
Bio & Medicine
Aug 5, 2014
0
0
A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.
Bio & Medicine
Oct 22, 2019
0
358
A crowdsourcing project which uses thousands of idling smartphones has helped to uncover anti-cancer properties of everyday foods and medicines.
Machine learning & AI
Jul 3, 2019
0
2
IBM announced its researchers have identified a new way to trigger the body's immune response by using polymer-coated graphene sheets. The research was recently published in Nature Communications.
Bio & Medicine
May 16, 2017
0
508
(Phys.org) —Researchers at the University of Southampton in the U.K. have devised a means for using nanoparticles to cause angiogenesis (the growth of new blood vessels) to speed up or slow down. In their paper published ...
(PhysOrg.com) -- University of Florida scientists have developed a new nanoparticle that could improve cancer detection and drug delivery. The particle, called a 'micelle' and made up of a cluster of molecules called aptamers, ...
Bio & Medicine
Feb 12, 2010
0
0
(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, ...
Bio & Medicine
Apr 6, 2012
1
0
While the primary job of DNA in cells is to carry genetic information from one generation to the next, some scientists also see the highly stable and programmable molecule as an ideal building material for nanoscale structures ...
Nanomaterials
Apr 27, 2011
0
0